Recent Update in the Diagnosis of Eustachian Tube Dysfunction: A Comprehensive Review of the Eustachian Tube Function Test
Article information
Abstract
Eustachian tube dysfunction (ETD) is a prevalent otolaryngologic condition that plays a central role in the pathogenesis of various middle ear diseases; however, there is no universally accepted gold-standard test for its diagnosis. In this narrative review, currently available Eustachian tube (ET) function tests are comprehensively evaluated, encompassing subjective patient-reported outcome measures and objective diagnostic modalities, with an assessment of their diagnostic accuracy, clinical utility, repeatability, and limitations. Patient-reported outcome measures, such as the Eustachian Tube Dysfunction Questionnaire-7, are valuable for symptom quantification, but they correlate poorly with objective ET function, and they cannot reliably differentiate between ETD subtypes. Among the objective tests, sonotubometry, tubomanometry, and the nine-step inflation-deflation test have the highest detected opening rates in healthy ears. Composite scoring systems, such as the Eustachian Tube Score-7, achieve superior diagnostic accuracy by integrating multiple test modalities. Advanced imaging techniques, including sitting computed tomography and dynamic magnetic resonance imaging, provide critical anatomical and functional information, particularly for patulous ETD and surgical planning. No single test provides a complete functional assessment; a combined diagnostic approach integrating validated patient-reported outcomes with objective function tests offers the most accurate characterization of ETD. Standardization of testing protocols, consensus reference standards, and international multicenter validation studies remain urgent priorities.
Introduction
Anatomy and physiology of the Eustachian tube
The Eustachian tube (ET) is a narrow canal connecting the nasopharynx to the middle ear, measuring approximately 31 to 38 mm in adults [1]. It comprises a constantly patent posterolateral osseous portion (one-third) and a normally collapsed anteromedial fibrocartilaginous portion (two-thirds), converging at the isthmus [1-3]. The cartilaginous portion functions as a dynamic valve, actively dilated primarily by the tensor veli palatini (TVP) muscle during swallowing, yawning, or sneezing [1,2,4]. This transient opening, occurring every 1 to 2 minutes and lasting 200 to 600 milliseconds, serves three essential functions: pressure equilibration between the middle ear and nasopharynx, drainage of middle ear secretions via mucociliary transport, and protection of the middle ear from nasopharyngeal pathogens in the resting closed state [1,5-7].
Eustachian tube dysfunction: definition and classification
Eustachian tube dysfunction (ETD) is broadly defined as a syndrome comprising a constellation of signs and symptoms suggestive of impairment in the normal functions of the ET [5]. According to the landmark consensus statement published by the European panel (EUSTAT) in 2015, ETD is classified into three major subtypes [5]. Dilatory (obstructive) ETD, the most common form, is characterized by the failure of the ET to open adequately for middle ear ventilation [5,6]. This subtype is further divided into functional obstruction, where persistent mucosal swelling or abnormal tubal compliance prevents opening; dynamic dysfunction involving muscular failure of the paratubal muscles to actively dilate the lumen; and anatomical (mechanical) obstruction caused by physical blockage such as adenoid hypertrophy or neoplasm [5,8]. Baro-challenge-induced ETD describes a condition in which the tube functions normally under ambient pressure conditions but fails to open adequately during rapid atmospheric pressure changes, such as those experienced during air travel or diving [5,9]. Patulous ETD (PET) is characterized by an ET that remains abnormally patent at rest, permitting the free transmission of sound and air from the nasopharynx to the middle ear [5,10].
The clinical presentation of ETD is varied and often nonspecific. Common symptoms include a sensation of aural fullness, hearing loss, tinnitus, and otalgia [5,11]. Patients with PET frequently present with autophony and aerophony, which are hallmark symptoms of the condition [5,12,13]. Importantly, distinguishing between obstructive and PET based solely on clinical history can be exceedingly difficult due to a significant overlap in symptoms, as both conditions may manifest with a predominant sensation of aural fullness or ear clogging [6,14,15]. This diagnostic ambiguity underscores the necessity for objective function tests to differentiate the underlying pathophysiology [6,16].
More recently, Alper, et al. [8] proposed an endotype-based classification that reframes ETD as a heterogeneous condition driven by distinct underlying mechanisms. This framework identifies four endotypes: ETD-I (inflammatory), characterized by mucosal swelling responsive to medical management; ETD-S (stricture), requiring mechanical intervention such as balloon dilation; ETD-R (restrictive/adenoid), amenable to adenoidectomy; and ETD-P (patulous) [8]. This mechanistic approach has important implications for treatment selection and may account for the variable outcomes observed in BET trials.
The need for reliable eustachian tube function testing
ETD is widely recognized as a primary etiological factor in the pathogenesis of various middle ear disorders. The failure of the ET to regulate pressure and clear secretions can lead to the development of otitis media with effusion (OME), tympanic membrane (TM) retraction, and chronic otitis media [8,17]. Persistent negative middle ear pressure resulting from chronic obstructive ETD promotes the formation of retraction pockets, which may eventually progress to cholesteatoma [3,18,19]. Furthermore, adequate ET function is considered critical for the successful outcome of middle ear surgeries such as tympanoplasty [3].
Despite the high prevalence of ETD and its significant impact on middle ear health, there is currently no universally accepted gold standard test for its diagnosis [3,17,20]. While numerous diagnostic methods have been developed over the past several decades, none have demonstrated sufficient reliability and validity to serve as a definitive reference standard [6,20]. In the absence of such a standard, current clinical diagnosis relies heavily on a combination of patient history, symptom reporting, and basic physical examinations including otoscopy and tympanometry [6,17]. Tympanometry, though ubiquitous, provides only an indirect assessment of tubal function at a single point in time, and a normal tympanogram does not exclude the presence of obstructive or PET [6].
The limitations of symptom-based diagnosis are substantial. The non-specific nature of patient complaints and the overlap in clinical presentation between different ETD subtypes make reliable differentiation based on history alone extremely difficult [6]. Patient-reported outcome measures (PROMs) such as the Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7), while useful for quantifying symptom severity, have limited diagnostic accuracy as standalone tools [6,16].
The demand for reliable, objective tests of ET function has grown substantially in recent years, driven in large part by the emergence of balloon Eustachian tuboplasty (BET) [6,8]. Accurate objective testing is critical for selecting appropriate surgical candidates, ensuring that the procedure is performed only on patients with verifiable dilatory dysfunction [6,8]. Moreover, there is a pressing need for objective outcome measures to validate treatment efficacy beyond subjective symptom improvement [6]. The current literature on BET underscores this problem: an analysis of 31 published studies identified over 27 different subjective and objective outcome measures, highlighting the urgent need for consensus on reliable testing protocols [6]. This review aims to comprehensively evaluate the current landscape of ET function testing, examining the validity, reliability, and clinical utility of all available diagnostic modalities to support the development of a standardized diagnostic pathway.
To construct this narrative review, a comprehensive literature search was performed in PubMed/MEDLINE, Embase, and the Cochrane Library from database inception through May 2025, using keyword combinations including “Eustachian tube,” “dysfunction,” “patulous,” “tubomanometry,” “sonotubometry,” “tympanometry,” “nine-step test,” “clinical maneuvers,” and “ETDQ-7.” English-language peer-reviewed articles were included, supplemented by hand-searching of retrieved bibliographies and relevant consensus statements and guidelines.
Subjective Measures: PROMs
Eustachian Tube Dysfunction Questionnaire-7
The ETDQ-7, developed by McCoul, et al. in 2012, is the most widely used disease-specific instrument for assessing the symptom burden of ETD [11,16]. The questionnaire consists of seven items addressing common symptoms: pressure in the ears, pain, a sensation of clogging or being “underwater,” ear symptoms during a cold or sinusitis, crackling or popping sounds, tinnitus, and muffled hearing [11,21]. Each item is rated on a Likert scale from 1 (no problem) to 7 (severe problem), yielding a total score range of 7 to 49 [11,22]. A total score of ≥14.5 (or a mean item score of ≥2.1) has been established as the diagnostic cut-off for ETD [11,16]. In its initial validation, the instrument demonstrated acceptable internal consistency (Cronbach’s α=0.71) and good test–retest reliability (r=0.78) [11,16].
The diagnostic accuracy of the ETDQ-7 has shown significant variability across studies. While the original validation reported 100% sensitivity and specificity when comparing clinically diagnosed ETD patients against healthy controls [11,16], this near-perfect separation reflects the characteristics of the derivation cohort and is unlikely to be reproduced in broader clinical populations; indeed, subsequent evaluations have yielded considerably lower values. When compared against objective function tests such as tubomanometry (TMM) or the inflation-deflation test, sensitivity has been reported to be as low as 45%–54%, and the area under the receiver operating characteristic curve (AUC) has been found to be relatively modest (e.g., 0.631) [16,21,23]. The ETDQ-7 has been translated and validated in multiple languages, reflecting its widespread clinical utility [3,6,21,24,25]. A minimal clinically important difference of greater than 3.5 for the total score has been applied to the ETDQ-7, a threshold traceable to the balloon dilation trial by Poe, et al. [26] and adopted in subsequent studies [22]. Reported symptom improvements following BET consistently exceed this threshold (total-score reductions of approximately 12 to 15 points) [20], although formal validation has identified item-level floor effects and a potential ceiling effect that may limit the questionnaire’s responsiveness across the full range of disease severity [22,23].
Despite its popularity, the ETDQ-7 has notable limitations. Multiple studies have demonstrated a weak correlation between ETDQ-7 scores and objective measures of ET function such as TMM and sonotubometry, suggesting that patientreported symptoms may not always reflect the true functional status of the tube [16,23,27,28]. The questionnaire cannot reliably differentiate between obstructive and PET, as symptoms such as aural fullness overlap significantly between the two conditions [16,22,23]. Furthermore, its validity is compromised in patients with TM perforations, where the classic symptoms of ETD may be attenuated or altered by the loss of the middle ear air cushion [17]. Consequently, the ETDQ-7 is best employed as a tool for symptom quantification and treatment monitoring rather than as a standalone diagnostic instrument.
Patulous Eustachian Tube Handicap Inventory-10
The Patulous Eustachian Tube Handicap Inventory-10 (PHI-10) was developed specifically to evaluate the severity of subjective symptoms and their impact on quality of life in patients with PET [29,30]. Adapted from the Tinnitus Handicap Inventory [31], this 10-item questionnaire quantifies patient handicap on a scale from 0 to 40, with scores of 0–8 indicating no handicap, 10–16 indicating mild handicap, 18–24 indicating moderate handicap, and 26–40 indicating severe handicap [29,30]. A score of ≥26 is strongly associated with severe subjective impairment and is frequently observed in definitive cases requiring active intervention [12,15]. The PHI-10 has demonstrated significant clinical utility in guiding management decisions, particularly regarding surgical interventions such as the Kobayashi plug (silicone plug) [12,32]. High scores are used to identify patients with intractable symptoms who are less likely to respond to conservative treatments, whereas patients with lower scores may be managed conservatively even if they exhibit objective signs of a patent ET [12,15]. Beyond these two principal instruments, other measures have been applied to ETD assessment. The Cambridge ETD Assessment (CETDA), a 10-item questionnaire designed to discriminate between obstructive and patulous phenotypes, demonstrated excellent internal consistency but ultimately failed to reliably distinguish the two subtypes and showed poor specificity against other otological conditions [23]. Visual analogue scales (VAS) are also frequently employed in clinical trials to quantify the severity of specific symptoms such as aural fullness, although they are generic rather than disease-specific [6,20]. The characteristics, diagnostic performance, and limitations of available PROMs are summarized in Table 1.
Tympanometry-Based Tests
Standard tympanometry
Standard tympanometry is the most widely used objective method for assessing middle ear status and indirectly evaluating ET function [6,33]. It classifies middle ear status based on the Jerger classification system, where a Type A tympanogram (peak pressure between +50 and -99 daPa) typically indicates normal middle ear aeration [5,34,35], whereas Type B (flat trace) and Type C (negative middle ear pressure) tympanograms serve as indicators of ETD [6,34]. Tympanic peak pressure functions as a surrogate marker for the ventilatory function of the ET, with values lower than -50 daPa being highly suggestive of obstructive ETD [6,36].
Despite its widespread use, standard tympanometry has significant limitations as a standalone diagnostic tool. Approximately 60% to 71% of patients with clinically diagnosed ETD present with a normal Type A tympanogram, indicating substantial insensitivity for mild or intermittent dysfunction [16,17,21]. Moreover, standard tympanometry typically appears normal in patients with PET, as the middle ear remains aerated [6,33], and it is inherently insufficient for diagnosing baro-challenge-induced ETD [9]. As a static assessment that measures resting middle ear pressure at a single point in time, standard tympanometry does not evaluate the dynamic capacity of the ET to open and equalize pressure [6,16]. To partially overcome this limitation, dynamic tympanometry can be performed by recording tympanograms before and after provocative maneuvers such as the Valsalva or Toynbee maneuver [9]. Nevertheless, standard tympanometry remains a useful first-line screening tool but is insufficient for comprehensive evaluation of ET function [6].
Inflation-deflation test
The inflation-deflation test evaluates the active ventilatory function of the ET by assessing its ability to equilibrate artificially induced pressure differentials between the middle ear and the nasopharynx [36,37]. The test involves applying a specific positive (+200 to +400 daPa) or negative (-200 to -400 daPa) pressure load to the middle ear through a sealed external auditory canal probe, then measuring the extent to which the patient can neutralize this pressure through repeated active swallowing [16,33,38].
The application of this test depends critically on the status of the TM. In ears with a perforation or patent ventilation tube, pressure is applied directly to the middle ear cavity, constituting a direct measure of ET physiologic function [16,33,38]. For ears with an intact TM, the nine-step inflation-deflation tympanometric test represents the adapted variant [33,38].
A key quantitative outcome measure is the percentage of pressure equilibrated after five swallows (PEq5), where a value of 100% indicates complete equilibration and a cutoff of less than 60% has been utilized to classify ears as having decreased ET function [8,16,36]. The diagnostic accuracy of the test shows moderate performance: one study reported 75% sensitivity and 65% specificity for overpressure equilibration, and when combined with additional manometric parameters, discriminant analysis achieved 95% sensitivity and 83% specificity [33,36]. Principal limitations include dependence on patient cooperation, significant inter-individual variability even among healthy populations (approximately 28% of healthy adults may fail to completely equilibrate applied pressures), and potential discomfort from the application of high pressures [1,33,38].
Nine-step test (Bluestone’s test)
The nine-step inflation-deflation tympanometric test was originally described by Bluestone, et al. in the 1970s and 1980s as a method to assess the pressure-equalizing function of the ET in individuals with an intact TM [1,39]. The procedure involves a sequence of nine steps alternating between tympanometric measurement of resting middle ear pressure, application of positive and negative pressures (+200 to +400 daPa) to the external auditory canal, and instructing the patient to swallow to equilibrate the induced pressure loads [38-40].
The primary diagnostic outcome is the maximal peak pressure difference (MPD), calculated as the difference between the peak pressures obtained during the inflation, deflation, and resting phases [40,41]. A higher MPD indicates better tubal function, reflecting the ET’s capacity to open and equalize artificially induced pressure gradients [39,42]. Recent investigations have sought to refine normative values: Bae, et al. [40,42] established an MPD cutoff of ≤13 daPa for diagnosing ETD, demonstrating 73.7% sensitivity and 90.0% specificity for differentiating obstructive ETD from healthy controls. Notably, a 2024 study by Wang, et al. in a Taiwanese cohort identified a considerably lower normative cutoff (MPD ≤4 daPa), suggesting that demographic factors or variations in device protocols may substantially influence normative data [39,41].
The nine-step test has recently proven valuable as an objective outcome measure for BET. Bae, et al. [42] demonstrated that BET significantly improved MPD values post-treatment compared to a medication-only control group, providing objective evidence of restored tubal function. The principal strengths of this test include its use of widely available tympanometric equipment and its relatively intuitive interpretation [9,39]. Limitations include the time required for administration, necessity for patient cooperation with sequential swallowing, restriction to ears with an intact TM, and conflicting normative data across populations [38,39,41,42]. Modern commercial immittance systems such as the GSI TympStar Pro and the Interacoustics Titan have incorporated automated ET function modules, improving clinical accessibility [39,40]. These commercial tests have demonstrated moderate diagnostic accuracy for obstructive ETD (AUC=0.875) and PET (AUC=0.769), though they remain limited to intact TMs [3,40].
For ears with TM perforations, the forced response test provides more detailed quantitative analysis of ET mechanics, though its use remains confined to research settings due to non-standardized equipment and reproducibility concerns [8,33,36,43].
Continuous impedance monitoring
Continuous impedance monitoring assesses ET function by recording real-time changes in TM compliance [44,45]. Unlike static tympanometry, this technique involves sealing a probe in the external auditory canal—typically generating a 226 Hz tone at 85 dB sound pressure level (SPL)—and continuously measuring the equivalent volume change of the middle ear system over time [44,45]. An ET opening event is defined as a deflection in the impedance trace of ≥0.05 mL from baseline [44-46]. In healthy ears, detected opening rates of 88% have been reported during the Valsalva maneuver, and 92.7% in a separate cohort [44,45], though detected opening rates during swallowing alone can be lower (45%–53%) [45]. The continuous nature of this modality makes it distinctively suitable for diagnosing PET, as it can identify characteristic breathing-synchronous fluctuations that serve as objective diagnostic markers [6,12].
Sonotubometry
Principle and methodology
Sonotubometry is a non-invasive, physiological test that assesses the ventilatory function of the ET by measuring sound transmission from the nasopharynx to the middle ear [47,48]. The principle relies on the fact that the normally closed ET attenuates sound transmission; during active opening, the tube becomes patent and allows sound energy to pass into the middle ear cavity, detected as a transient increase in the SPL within the external auditory canal [37,44]. Unlike manometric tests, sonotubometry can be performed on ears with intact TMs and does not require non-physiological pressure gradients [6,48].
The basic instrumentation comprises a sound generator inserted into the nostril, a microphone sealed within the ipsilateral external auditory canal, and a signal processing unit [44,47,48]. Various acoustic stimuli have been employed, ranging from pure tones (6–8 kHz) to broadband noise and perfect sequences (PSEQ), a periodic deterministic signal allowing determination of the impulse response of the transmission link [37,48-50]. Recent research has also explored click trains and swept frequencies (chirps) to analyze phase shifts as indicators of ET patency [51,52].
Diagnostic performance
Sonotubometry is recognized for its high sensitivity in detecting ET opening in healthy individuals. Smith, et al. [45] reported a detected opening rate of 94% using dry swallows, the highest among six different tests evaluated. Ruan, et al. [44] observed a comparable rate of 90.9%. The diagnostic accuracy for identifying obstructive ETD varies: using a clinical expert panel diagnosis as reference, sonotubometry demonstrated 63% sensitivity and 79% specificity [53]. When compared to a gold standard of pressure equilibration, Swarts, et al. [47] reported 74.2% sensitivity and 65.6% specificity for correctly identifying a true ET opening event. More recently, Lee, et al. [54] reported that a sound level change cutoff of >6.435 dB offered 92.5% sensitivity and 73.2% specificity for distinguishing normal ears from those with dilatory ETD. Representative sonotubometric tracings illustrating the distinct signal patterns associated with each functional category are presented in Fig. 1.
Representative sonotubometry tracings according to Eustachian tube (ET) functional status. A: Normal ET function. A transient increase in sound transmission is detected during swallowing, reflecting ET opening. B: Dilatory ET dysfunction. No increase in sound transmission is detected during swallowing, consistent with failure of ET opening. C: Patulous ET‒open plateau pattern. Prolonged elevation of sound transmission following swallowing indicates delayed ET closure. D: Patulous ET‒continuous pattern. Persistently elevated sound transmission is present at rest without discrete swallow-related events.
Sonotubometry with postural change (Ohta method)
The Ohta method is a specialized sonotubometric technique developed to diagnose PET by exploiting the condition’s characteristic positional dependency [12,55]. In PET patients, the abnormally patent tube closes when supine due to venous engorgement of the peritubal tissues, specifically the pterygoid venous plexus [12,55]. The test measures sound transmission in the upright position—where a low presented sound pressure level (PSPL<100 dB) indicates patency [12,56]—and compares this with the head-down position, where PSPL returns to normal levels as the tube closes [12,55]. A change in sound transmission exceeding 15 dB between positions has been identified as a diagnostic cutoff for definite PET [12,55]. The Japan Otological Society (JOS) diagnostic criteria for PET incorporate these principles, listing symptom improvement with posture change as a key diagnostic component [15,56].
Strengths and limitations
Sonotubometry possesses several distinct advantages: it is completely non-invasive, assesses function under physiologi-cal conditions, and can be performed on ears with either intact or perforated TMs [6,44,47,57]. However, widespread clinical adoption has been hindered by signal-to-noise ratio challenges, as pharyngeal muscle movements during swallowing generate background noise that can produce artifacts [47,51]. There is no universally accepted standard configuration, with protocols varying in stimulus type, opening criteria, and maneuver selection [47,51]. The choice of maneuver significantly impacts performance: dry swallows produce larger and longer duration peaks compared to wet swallows [45]. Despite high sensitivity in healthy ears, the diagnostic accuracy for obstructive ETD can be modest when sonotubometry is used as a standalone tool [53].
Tubomanometry
Principle and procedure
TMM, originally described by Esteve in 2001, is a semi-objective manometric method that quantifies the active transport of gas from the nasopharynx to the middle ear [21,58,59]. The procedure involves delivering a defined hyperpressure bolus to the nasopharynx through a sealed nasal applicator at three sequential pressure levels: 30, 40, and 50 mbar [59,60]. Pressure application is triggered by the patient’s swallow; as the soft palate closes the velopharyngeal port, the device detects the intranasal pressure rise and releases the pre-set air bolus [21,61]. Simultaneously, a pressure receptor probe sealed within the external auditory canal monitors for pressure transfer [44,59].
The primary quantitative outcome measure is the opening latency index (R value), calculated as R=(P1–C1)/(C2–C1), where P1 indicates the onset of ear canal pressure change, C1 the onset of nasopharyngeal pressure rise, and C2 the peak nasopharyngeal pressure [59,61]. An R value of ≤1 indicates immediate (“early”) opening and is considered normal, R>1 indicates delayed opening suggestive of dysfunction, and absence of a detectable R value indicates complete obstruction [21,59,61]. Schematic pressure tracings illustrating these three functional states are presented in Fig. 2. The multi-level pressure assessment helps quantify severity of dysfunction: a tube opening only at higher pressures indicates a different functional status than one that remains closed at all levels [34,44,59].
Schematic tubomanometry tracings in three ET functional states. Each panel shows ear canal pressure (upper trace) and nasopharyngeal pressure (lower trace). C1 and C2 indicate the onset and peak of the nasopharyngeal pressure bolus; P1 indicates the onset of the ear canal pressure response. A: Normal ET function. The ear canal pressure rises before peak nasopharyngeal pressure (R<1), indicating immediate ET opening. B: Obstructive ET dysfunction. No ear canal pressure change is detected despite adequate nasopharyngeal pressurization (R: not measurable). C: Patulous ET. Persistent rhythmic oscillations in ear canal pressure indicate continuous passive pressure transmission through a permanently patent ET. ET, Eustachian tube; R, opening latency index; mbar, millibar.
Eustachian Tube Score
The Eustachian Tube Score (ETS) is a composite scoring system integrating subjective symptoms with TMM findings [3,6]. The original ETS (ETS-5) consists of five items—three TMM measurements and two subjective assessments (Valsalva ability and clicking sound during swallowing)—each scored 0–2, yielding a range of 0–10 with ≤5 indicating pathological ETD [3,17]. Because it does not rely on tympanometry, the ETS-5 is specifically adapted for patients with perforated TMs [3,17].
The extended ETS-7 adds tympanometry and objective Valsalva assessment, yielding a range of 0–14 with a cutoff of ≤7 [3,6,21]. Schröder, et al. [3] reported that the ETS-7 achieved 96% sensitivity and 96% specificity (AUC=0.98) for diagnosing chronic obstructive ETD, while the ETS-5 showed 91% sensitivity and 86% specificity. Both scores demonstrate excellent test–retest reliability (intraclass correlation coefficient 0.82 for ETS, 0.87 for ETS-7) [3]. A related combined approach, the T-ETDQ developed by Lu, et al. [62], integrates TMM findings with ETDQ-7 scores and has demonstrated good discriminant validity for diagnosing ETD in patients with intact TMs.
Clinical applications
TMM serves as a critical tool for evaluating BET efficacy, with studies demonstrating significant post-operative improvements in R values [34]. A recent double-blind randomized controlled trial observed objective ETS improvement in the BET group, although similar improvement was noted in the sham group [63]. However, preoperative TMM values may not reliably predict subjective symptom resolution [34]. TMM is also increasingly utilized in multivariate diagnostic models; a nomogram integrating the ETS-5 with endoscopic grading of nasopharyngeal mucosal inflammation achieved an AUC of 0.901 for diagnosing ETD in patients with TM perforations [17].
Strengths and limitations
TMM offers a standardized, semi-objective assessment with controlled pressure delivery, reducing variability related to patient effort [34,61]. It is applicable to both intact and perforated TMs [6,59]. However, the test requires specialized equipment that is expensive and not widely available [6,34]. Technical challenges include obtaining airtight seals, and some studies suggest that the R value may lack specificity: Alper, et al. reported 93% sensitivity but only 44% specificity, potentially overestimating good function [61,64]. This apparent discrepancy with the higher specificity of the ETS-7 (96%) reflects the difference between a single R value parameter, which is prone to false-positive openings, and a composite score that integrates multiple independent items to improve specificity [3]. In comparative studies, TMM at 50 mbar achieved a 94.5% detected opening rate in healthy ears, comparable to sonotubometry (90.9%) [44].
Tubo-Tympano-Aerodynamic Graphy
Tubo-tympano-aerodynamic graphy (TTAG) is one of the primary objective methods for examining ET function in Japan, integrated into the JOS diagnostic criteria using specific commercial equipment (e.g., JK-05A, RION Co.) [37,44]. The principle involves simultaneous measurement of pressure changes in the external auditory canal and the nasopharynx during dynamic maneuvers such as the Valsalva maneuver or sniffing [37,44,65].
The JOS manual describes distinct waveforms for different functional states [37]. In normal function, the Valsalva maneuver produces ear canal pressure elevation (passive opening) followed by pressure release upon swallowing (active opening). In obstructive ETD, despite sufficient nasopharyngeal pressure elevation, no corresponding ear canal pressure change is observed. In PET, the hallmark pattern is fluctuation of ear canal pressure synchronous with respiration [12,15]. The manual by Ikeda, et al. [37] recommends TTAG particularly for diagnosing PET and assessing ET closing failure. Representative waveform patterns illustrating these three functional states are shown in Fig. 3.
Representative TTAG waveform patterns in ET dysfunction. A: Normal ET function. The Valsalva maneuver produces ear canal pressure elevation (passive opening), which is subsequently released by swallowing (active opening). B: Obstructive ET dysfunction. Despite adequate nasopharyngeal pressurization (>650 daPa), no corresponding ear canal pressure change is observed. C: Patulous ET. Ear canal pressure fluctuates rhythmically in synchrony with respiration, reflecting unrestricted pressure transmission through a persistently patent ET. ET, Eustachian tube; TTAG, tubo-tympano-aerodynamic graphy; daPa, decapascals.
TTAG provides comprehensive real-time assessment and is considered highly specific for detecting PET [15,44]. However, its global adoption is limited by equipment availability outside Japan [9,66], complexity of interpretation including susceptibility to artifacts from jaw movement [37], poor correlation between pressure transmission ratios and morphological severity [10,55], and reliance on non-physiological maneuvers [44].
Endoscopic and Imaging-Based Assessment
Video nasopharyngoscopy
Transnasal video endoscopy allows direct visualization of the nasopharyngeal orifice of the ET during swallowing, yawning, and phonation, enabling assessment of the sequential dilation phases that constitute normal ET opening [4,67,68]. In dilatory dysfunction, reduced lateral wall excursion is a hallmark finding, whereas PET is characterized by a concave defect in the superior cartilaginous wall with persistent patency at rest [68]. The primary clinical utility lies in identifying underlying pathophysiology, confirming PET, and detecting extrinsic causes of dysfunction such as adenoid hypertrophy [6,68].
Computed tomography
High-resolution computed tomography (CT) provides detailed visualization of the bony and soft tissue anatomy of the ET, with multiplanar reconstruction techniques essential for precise measurement of lumen dimensions [2,69]. A particularly important application is sitting CT for PET diagnosis. Standard supine CT often masks the diagnosis because venous engorgement causes the patent tube to close when lying flat [2,12]. Kikuchi, et al. [69] demonstrated that sitting 3DCT could visualize a completely open ET in PET patients, achieving 100% specificity. Sitting CT also allows measurement of the cross-sectional area, which correlates with functional severity [10,55].
CT imaging is integral to surgical planning. Preoperative CT before BET is recommended to rule out carotid canal dehiscence [2,70]. Valsalva CT can localize the site of obstruction, visualizing the distal cartilaginous portion in up to 94% of ears; BET may be contraindicated when obstruction is in the bony portion [66,71]. For PET, sitting CT provides morphological data crucial for Kobayashi plug sizing [10,15]. Lowdose cine CT has also been explored to capture real-time air bolus transit through the ET, offering dynamic assessment complementary to static imaging [2,72].
Magnetic resonance imaging
Magnetic resonance imaging (MRI) offers superior soft tissue contrast, making it the modality of choice for visualizing non-bony ET components [2,73]. T1-weighted images effectively visualize Ostmann’s fat pad and the TVP and levator veli palatini muscles, while dynamic MRI using real-time turbo-gradient echo sequences allows visualization of ET opening during maneuvers [2,73]. Oshima, et al. used MRI to demonstrate that pterygoid venous plexus engorgement causes ET compression in the supine position, explaining PET’s postural dependency [2,12,74]. MRI voxel data has also been used to generate 3D biomechanical models of the ET and surrounding musculature [2,75].
Clinical Maneuvers
Several clinical maneuvers are routinely employed to assess ET patency. The outcome of these maneuvers can be evaluated in two fundamentally different ways: subjectively, based on the patient’s perception of pressure change or aural sensation, or objectively, based on demonstrated tube opening through otoscopic observation of TM movement, tympanometric pressure shift, or other instrumented measurement. This distinction is clinically important, because subjectively reported success does not always correspond to objectively confirmed tubal opening, and reported success rates vary accordingly depending on the assessment method used. The Valsalva maneuver assesses passive opening under high nasopharyngeal pressure; when success is defined subjectively by the patient’s sensation of pressure release, a success rate of approximately 89% is reported in healthy adults [3], whereas objective confirmation by TM movement is observed in 78%–85% of healthy ears [38,45]. However, approximately 31% of patients with normal middle ear pressure may fail to perform the maneuver adequately [76], and it is non-physiological and highly effort-dependent [28,45]. The Toynbee maneuver, involving swallowing while the nose is pinched, is more physiological but less effective, with objectively consistent findings in only 56% of healthy ears [45,59].
The Politzer method, originally using a rubber bulb and now adapted with automated devices (e.g., middle ear infla-tion device), delivers a controlled air bolus during swallowing [38,77]. This approach bypasses patient-generated pressure variability and, when assessed objectively by otoendoscopic confirmation of TM bulging, has achieved success rates of approximately 88% with modern devices [76], demonstrating superior reliability compared to the Valsalva maneuver [76,78,79]. The sniff test, involving rapid forceful nasal inhalation, is particularly valuable for diagnosing PET and ET closing failure [37,44]; in healthy ears, objectively detected opening rates are low (30%–46%) [45].
Comparative Analysis of Eustachian Tube Function Tests
Diagnostic accuracy
No single test satisfies the criteria for a gold standard, with diagnostic accuracy varying considerably across modalities [33]. In healthy ears, several objective tests achieve comparably high detected opening rates with no significant difference among them (Table 2); the choice of maneuver, however, significantly influences results, with swallowing favoring sonotubometry and the Valsalva maneuver favoring impedancebased and TTAG tests [44,45]. Test selection should therefore depend on the specific clinical indication and available equipment [44].
Test selection by tympanic membrane status
The status of the TM fundamentally determines test applicability. For intact membranes, standard tympanometry, the nine-step test, and continuous impedance monitoring are primarily employed, with the pressure chamber test reserved as the reference standard for baro-challenge ETD [3,6,16,40,47]. For perforated membranes, the inflation-deflation test and forced response test are the standard methods, with ETS-5 offering a validated composite assessment [16,33,36]. TMM, sonotubometry, TTAG, and transnasal endoscopy remain applicable regardless of membrane status; for composite scoring, the ETS-7 is adapted for intact membranes and the ETS-5 for perforated membranes [3,17,33,47]. A comprehensive summary is provided in Table 2.
Test selection by ETD subtype
The physiological basis of each test determines its suitability for specific ETD subtypes. Obstructive ETD is characterized by failure of active tubal opening; accordingly, tests that directly measure the pressure-equalizing or sound-transmitting capacity of the ET during active maneuvers—such as TMM, sonotubometry, and the nine-step test—are most appropriate [12,40,53,64]. PET, by contrast, is defined by persistent tubal patency at rest; diagnosis therefore requires detection of passive respiratory-synchronous pressure or impedance fluctuations, making TTAG and continuous impedance monitoring the most specific modalities [37,44]. The positional dependency of PET further supports the use of the Ohta method and sitting CT, which exploit venous engorgement-mediated tubal closure in the supine position [12,55,69]. The JOS manual accordingly recommends TTAG and sonotubometry as primary tests for PET, with the inflation-deflation test preferred for stenotic ears with perforations [37]. Across all subtypes, the absence of standardized protocols and universal reference standards remains a major barrier to consistent test selection and interpretation [5,53].
Clinical Application and Diagnostic Algorithms
Proposed diagnostic pathway
Based on the available evidence, a stepwise diagnostic pathway can be proposed. The first step involves a thorough clinical history, otoscopy, and standard tympanometry as a screening measure [5,53]. While normal tympanometry does not exclude ETD, Type B or C tympanograms provide objective support for clinical suspicion [5,53]. The second step employs validated questionnaires for symptom quantification: the ETDQ-7 for suspected obstructive ETD (cutoff ≥14.5) and the PHI-10 for suspected PET [11,12,24,53].
The third step requires objective ET function testing. For obstructive ETD with an intact membrane, sonotubometry and TMM are recommended for their superior diagnostic performance [53]. The nine-step test offers a practical alternative using widely available equipment [40]. For PET, TTAG or continuous impedance monitoring should document respiratory-synchronous TM movements [12,53], and the Ohta method provides additional confirmation [12]. Because obstructive and PET share overlapping symptoms, the initial subtype assignment is provisional; if subtype-specific testing is non-diagnostic, evaluation for the alternative subtype is warranted. The fourth step, advanced imaging, is reserved for surgical planning: sitting CT confirms PET [2,12], and Valsalva CT localizes obstruction sites [66,71]. Preoperative CT considerations for BET are detailed in Sections 7.2 and 10.2. A schematic overview of this proposed stepwise diagnostic pathway is illustrated in Fig. 4.
Proposed stepwise diagnostic algorithm for ETD. The pathway consists of four sequential steps. Step 1 involves clinical evaluation including history, otoscopy, and standard tympanometry. Step 2 employs symptom quantification using the ETDQ-7 (cutoff ≥14.5) for suspected obstructive ETD or the PHI-10 for suspected patulous ETD. At Step 3, the algorithm bifurcates by subtype: obstructive ETD is assessed with sonotubometry, TMM, the nine-step test, or the ETS-7 composite score; patulous ETD is evaluated with TTAG, continuous impedance monitoring, or the Ohta method, with testing for the alternative subtype warranted when initial testing is non-diagnostic. Step 4 advanced imaging is reserved for surgical planning only. ETD, Eustachian tube dysfunction; ETDQ-7, Eustachian Tube Dysfunction Questionnaire-7; PHI-10, Patulous Eustachian Tube Handicap Inventory-10; TMM, tubomanometry; ETS-7, Eustachian Tube Score-7; TTAG, tubo-tympano-aerodynamic graphy; CT, computed tomography; PET, patulous Eustachian tube.
Combined approaches have shown substantial promise. The T-ETDQ system integrating TMM with the ETDQ-7, and diagnostic nomograms incorporating multiple clinical variables (AUC up to 0.901), represent important advances toward a more reliable diagnostic framework [17,21].
Testing in specific clinical contexts
Balloon Eustachian tuboplasty
BET is indicated for patients with symptoms of obstructive ETD persisting for more than 3 months despite medical management [5,20]. TMM is increasingly used to confirm pathological R values [34,59]. It is critical to exclude PET prior to BET [34,53]. Preoperative temporal bone CT is mandatory to exclude anatomical contraindications such as carotid canal dehiscence (Section 7.2) [2,70,80]. Post-operative assessment combines ETDQ-7 score reduction with objective functional changes including R value improvement, tympanogram normalization, and ETS improvement [63,80-82].
Chronic otitis media and tympanoplasty planning
The relationship between preoperative ET function and tympanoplasty success remains debated [17]. In perforated membranes, the ETS-5 or inflation-deflation test is recommended, and nomogram models integrating TMM with endoscopic findings may improve diagnostic accuracy [17,33].
Baro-challenge-induced ETD
The nine-step test is considered the most useful single officebased test for this subtype because it directly simulates ambient pressure changes, with reported 91% sensitivity and 100% specificity for predicting barotrauma [9,40]. The pressure chamber test remains the reference standard for this subtype, as it uniquely replicates the physiological stress of rapid atmospheric pressure changes in a controlled setting, though its availability is restricted to specialized research centers [5,9,47,53].
ETD in chronic rhinosinusitis
ETD is highly prevalent in chronic rhinosinusitis patients (15%–68%), and endoscopic sinus surgery alone significantly reduces ETD symptoms [80,83]. Randomized controlled trials demonstrate that combining BET with sinus surgery results in significantly greater improvement (92% vs. 68% improvement ratio) compared to sinus surgery alone [80].
Pediatric considerations
The pediatric ET is shorter, more horizontal, and has more compliant cartilage with a less efficient TVP mechanism, predisposing children to functional obstruction and OME [1,2]. These differences also limit the applicability of most function tests [53,84]. Patient-reported measures are of little use: even with caregiver assistance, children under 12 struggle to reliably self-report subjective aural symptoms such as pressure or muffled hearing, and no independently validated pediatric ETDQ-7 has been established, so extrapolation of adult questionnaire data is discouraged [16,53]. Children with cleft palate, in whom abnormal TVP anatomy causes profound active opening failure, warrant particular attention [1,7]; as they usually have ventilation tubes or perforations, the inflation-deflation test (applying ±200 daPa to assess passive opening and active equilibration) remains the most appropriate objective assessment [37,85].
Objective physiological tests are feasible but limited in children [53,84]. Sonotubometry is painless and applicable regardless of membrane status, but its opening-detection rate is well below the adult level and falls further with effusion owing to acoustic dampening [33,48], while manometric tests (TMM, TTAG) require effort-dependent maneuvers many young children cannot perform [84]. Although a pediatric normative TMM R value of 1.12 has been proposed, further validation in pathological pediatric cohorts is needed before these tests can serve as routine screening tools [84].
Consensus statements and guidelines
The JOS Eustachian Tube Committee [37] published an English-language manual recommending TTAG and sonotubometry for PET diagnosis, with the inflation-deflation test preferred for stenotic ears. The JOS diagnostic criteria for definite PET require three elements: 1) subjective symptoms, 2) symptom relief by physical obstruction of the tube, and 3) at least one positive objective finding from TTAG, sonotubometry, or respiratory TM movement [37,56].
Future Directions
Several critical areas of development are poised to advance ET function testing. Foremost is the need for a standardized, widely available, and validated test battery [5,53]. Currently, widely available tests such as tympanometry lack specificity, while more accurate tests remain confined to specialized centers [33,44]. Future efforts must include refining sonotubometry with standardized stimuli (e.g., PSEQ) to improve reliability [51,57].
The absence of a gold standard remains a major impediment [16,53]. Latent class analysis, combining results from multiple imperfect tests to construct a more accurate reference diagnosis, represents a promising analytical approach [53,86,87]. International consensus statements by the EUSTAT panel and JOS provide foundational steps [5,37].
Machine learning and artificial intelligence (AI)-assisted interpretation may address challenges in differentiating true tubal opening signals from artifacts [51,57], and nomogram models integrating multiple variables have already demonstrated superior accuracy (AUC=0.901) [17]. Dynamic imaging advances including real-time MRI are being refined to capture ET opening dynamics [2,73].
Research into ETD endotypes—inflammatory, stricture, active muscular, and patulous—is shifting the paradigm toward targeted characterization and precision medicine approaches [8]. Standardized core outcome sets combining validated PROMs with objective data are critical for interventional trials [5,20,53], and international multicenter validation studies are essential [17,20,63].
Conclusion
This review has provided a comprehensive evaluation of the current landscape of ET function testing. The field remains characterized by a diversity of diagnostic approaches, none of which individually constitutes a gold standard. Each test evaluates different aspects of ET function—pressure equilibration, sound transmission, or anatomical patency—and no single modality provides a complete functional assessment.
PROMs, led by the ETDQ-7, are valuable for quantifying symptom burden and monitoring treatment response but correlate poorly with objective ET function and cannot differentiate between ETD subtypes. Among objective tests, sonotubometry, TMM, and the nine-step inflation-deflation test demonstrate the most promising combination of sensitivity, specificity, and clinical feasibility. Composite scoring systems such as the ETS-7, which integrate subjective and objective data, achieved the highest diagnostic accuracy (AUC=0.98) in a single-center derivation cohort, though independent external validation is still needed. Advanced imaging modalities, particularly sitting CT and dynamic MRI, provide irreplaceable anatomical and functional information for PET diagnosis and surgical planning.
The evidence strongly supports a combined diagnostic approach, where validated symptom questionnaires are paired with objective function tests in a stepwise algorithm tailored to the suspected ETD subtype and clinical context. Standardization of testing protocols, establishment of international consensus on diagnostic criteria, development of accessible test batteries for routine clinical use, and execution of multicenter validation studies represent the most pressing priorities for advancing this field toward more reliable diagnosis and evidence-based management of ETD.
Notes
Conflicts of Interest
The authors have no financial conflicts of interest.
Author Contributions
Conceptualization: Han-Seul Na, Sung-Won Choi. Data curation: Han-Seul Na, Dong-Hoon Lee. Formal analysis: Han-Seul Na. Funding acquisition: Sung-Won Choi. Investigation: Dong-Hoon Lee. Methodology: Han-Seul Na, Sung-Won Choi. Project administration: Sung-Won Choi. Resources: Dong-Hoon Lee. Software: Han-Seul Na. Supervision: Sung-Won Choi. Validation: Han-Seul Na, Dong-Hoon Lee. Visualization: Han-Seul Na, Dong-Hoon Lee. Writing—original draft: Han-Seul Na. Writing—review & editing: Han-Seul Na, Sung-Won Choi. Approval of final manuscript: all authors.
Funding Statement
This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2023-00223764). This research was also supported by a clinical research grant from Pusan National University Hospital in 2026.
Acknowledgments
None
